Literature DB >> 18307071

Prospective study to assess risk factors for pelvic floor dysfunction after delivery.

Maurizio Serati1, Stefano Salvatore, Vik Khullar, Stefano Uccella, Evelina Bertelli, Fabio Ghezzi, Pierfrancesco Bolis.   

Abstract

BACKGROUND: To identify obstetric risk factors for de novo pelvic floor disorders after vaginal delivery.
METHODS: Antenatally asymptomatic women who delivered vaginally were interviewed on urinary, anal and sexual disorders antenatally, 6 and 12 months postpartum.
RESULTS: Of 967 women, 336 were included for final analysis. Urinary symptoms occurred in 27 and 23% of women at 6 and 12 months postpartum: univariate analysis showed a significant relation to the use of epidural analgesia (p =0.04) and to a second stage of labour >1 h (p =0.02), the latter was confirmed significant by multivariate analysis. Anal incontinence occurred in 7.1 and 6.8% of women at 6 and 12 months postpartum, respectively. Dyspareunia was reported by 24% at 6 months, decreasing to 8% at 12 months (p <0.0001).
CONCLUSIONS: Our study shows that a second stage longer than 1 h is associated with the development of postpartum urinary incontinence. Except for dyspareunia, pelvic floor dysfunction rarely resolves spontaneously.

Entities:  

Mesh:

Year:  2008        PMID: 18307071     DOI: 10.1080/00016340801899008

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  22 in total

1.  Pelvic floor muscle strength predicts stress urinary incontinence in primiparous women after vaginal delivery.

Authors:  Sabrina Mattos Baracho; Lucas Barbosa da Silva; Elza Baracho; Agnaldo Lopes da Silva Filho; Rosana Ferreira Sampaio; Elyonara Mello de Figueiredo
Journal:  Int Urogynecol J       Date:  2012-03-01       Impact factor: 2.894

2.  Vaginal birth and pelvic floor dysfunction revisited: Can cesarean delivery be protective?

Authors:  Maurizio Serati; Diaa Rizk; Stefano Salvatore
Journal:  Int Urogynecol J       Date:  2015-12-03       Impact factor: 2.894

3.  Dyspareunia and pelvic floor muscle function before and during pregnancy and after childbirth.

Authors:  M K Tennfjord; G Hilde; J Stær-Jensen; M Ellström Engh; K Bø
Journal:  Int Urogynecol J       Date:  2014-04-01       Impact factor: 2.894

4.  An observational follow-up study on pelvic floor disorders to 3-5 years after delivery.

Authors:  Karen Ng; Rachel Yau Kar Cheung; Lai Loi Lee; Tony Kwok Hung Chung; Symphorosa Shing Chee Chan
Journal:  Int Urogynecol J       Date:  2017-02-14       Impact factor: 2.894

5.  Factors involved in stress urinary incontinence 1 year after first delivery.

Authors:  Irene Diez-Itza; Miren Arrue; Larraitz Ibañez; Arantzazu Murgiondo; Jone Paredes; Cristina Sarasqueta
Journal:  Int Urogynecol J       Date:  2009-11-26       Impact factor: 2.894

6.  Is cesarean section a real panacea to prevent pelvic organ disorders?

Authors:  Onder Koc; Bulent Duran; Safak Ozdemırcı; Yesim Bakar; Nuriye Ozengin
Journal:  Int Urogynecol J       Date:  2011-05-28       Impact factor: 2.894

Review 7.  Preventing urinary incontinence during pregnancy and postpartum: a review.

Authors:  Stian Langeland Wesnes; Gunnar Lose
Journal:  Int Urogynecol J       Date:  2013-02-23       Impact factor: 2.894

8.  The relationship between depressive/anxiety symptoms during pregnancy/postpartum and sexual life decline after delivery.

Authors:  Alexandre Faisal-Cury; Hsiang Huang; Ya-Fen Chan; Paulo Rossi Menezes
Journal:  J Sex Med       Date:  2013-02-22       Impact factor: 3.802

9.  Comment on the long-term effects of vacuum extraction on pelvic floor function: a cohort study in primipara.

Authors:  Maurizio Serati; Valerio Iacovelli; Andrea Braga
Journal:  Int Urogynecol J       Date:  2016-08-15       Impact factor: 2.894

10.  Prevalence of urinary and fecal incontinence in Chinese women during and after their first pregnancy.

Authors:  Symphorosa S C Chan; Rachel Y K Cheung; K W Yiu; L L Lee; Tony K H Chung
Journal:  Int Urogynecol J       Date:  2012-12-11       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.